(4-Bromobenzyl)hydrazine hydrochloride

Catalog No.: 
ACLBDV479
CAS No.: 
1727-08-8
Molecular Formula: 
C7H10BrClN2
Molecular Weight: 
237.53
(4-Bromobenzyl)hydrazine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$114.00In stockInquiry
25g95%$476.00In stockInquiry
100g95%$1600.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-Bromobenzyl)hydrazine hydrochloride
IUPAC Name(4-bromobenzyl)hydrazine hydrochloride
MDL No.MFCD12031977
Molecular FormulaC7H10BrClN2
Molecular Weight237.53
SMILESNNCC1=CC=C(Br)C=C1.[H]Cl
InChI KeyJNYUWAFJQNITFC-UHFFFAOYSA-N
Synonym4-BroMobenzylhydrazine hydrochloride;[(4-bromophenyl)methyl]hydrazine hydrochloride;4-BROMOBENZYLHYDRAZINE HCL
CAS No.1727-08-8
PubChem CID90487857

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACLBDV479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGPLR128 route compound structure diagram
    ACGPLR1281122-91-4In Stock
  4. Then
  5. ACLBDV479 route product structure diagram
    ACLBDV4791727-08-8In Stock
Inquiry

2. ACLBDV479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLBDV479 route product structure diagram
    ACLBDV4791727-08-8In Stock
Inquiry

3. ACLBDV479 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLBDV479 route product structure diagram
    ACLBDV4791727-08-8In Stock
Inquiry

Comments (0)